An overview of point-of-care testing for infections in critically ill patients
INTRODUCTION: Molecular diagnostic systems for point-of-care (POC) testing are nowadays routinely used and are part of many labs. Although often intended for bedside use outside of the microbiology lab, there is still room for expansion.
AREAS COVERED: This review discusses the two techniques that are currently the most widespread, real-time polymerase-chain reaction (RT-PCR) and loop-mediated isothermal amplification (LAMP). An overview is provided of the various manufacturers and products as well as the evidence and current use in clinical practice. The article further sheds light on some newer techniques, such as CRISPR-based diagnostics and lab-on-a-chip, which are still in development.
EXPERT OPINION: With many new platforms and techniques still in the pipeline and their potential currently not yet fully exploited, we expect the use of molecular POC testing to increase in the years to come. However, even when used in hospital - in lab, the main advantages of the tests being fast and easy to perform already provide significant benefits in terms of patient outcome.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
Expert review of molecular diagnostics - 24(2024), 3 vom: 27. März, Seite 193-200 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Moerman, Alena [VerfasserIn] |
---|
Links: |
---|
Themen: |
CRISPR-based diagnostics |
---|
Anmerkungen: |
Date Completed 25.03.2024 Date Revised 25.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/14737159.2024.2322146 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369042778 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369042778 | ||
003 | DE-627 | ||
005 | 20240325235001.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240229s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/14737159.2024.2322146 |2 doi | |
028 | 5 | 2 | |a pubmed24n1346.xml |
035 | |a (DE-627)NLM369042778 | ||
035 | |a (NLM)38414348 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Moerman, Alena |e verfasserin |4 aut | |
245 | 1 | 3 | |a An overview of point-of-care testing for infections in critically ill patients |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.03.2024 | ||
500 | |a Date Revised 25.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a INTRODUCTION: Molecular diagnostic systems for point-of-care (POC) testing are nowadays routinely used and are part of many labs. Although often intended for bedside use outside of the microbiology lab, there is still room for expansion | ||
520 | |a AREAS COVERED: This review discusses the two techniques that are currently the most widespread, real-time polymerase-chain reaction (RT-PCR) and loop-mediated isothermal amplification (LAMP). An overview is provided of the various manufacturers and products as well as the evidence and current use in clinical practice. The article further sheds light on some newer techniques, such as CRISPR-based diagnostics and lab-on-a-chip, which are still in development | ||
520 | |a EXPERT OPINION: With many new platforms and techniques still in the pipeline and their potential currently not yet fully exploited, we expect the use of molecular POC testing to increase in the years to come. However, even when used in hospital - in lab, the main advantages of the tests being fast and easy to perform already provide significant benefits in terms of patient outcome | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a CRISPR-based diagnostics | |
650 | 4 | |a POC testing | |
650 | 4 | |a lab-on-a-chip | |
650 | 4 | |a loop-mediated isothermal amplification (LAMP) | |
650 | 4 | |a real-time polymerase chain reaction (RT-PCR) | |
700 | 1 | |a De Waele, Jan J |e verfasserin |4 aut | |
700 | 1 | |a Boelens, Jerina |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Expert review of molecular diagnostics |d 2001 |g 24(2024), 3 vom: 27. März, Seite 193-200 |w (DE-627)NLM117852775 |x 1744-8352 |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2024 |g number:3 |g day:27 |g month:03 |g pages:193-200 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/14737159.2024.2322146 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 24 |j 2024 |e 3 |b 27 |c 03 |h 193-200 |